Executive Director
ICASE, Indiana
Christopher J. Welch is the Executive Director of the Indiana Consortium for Analytical Sciences and Engineering (ICASE), a joint venture between Purdue, Notre Dame and Indiana University. He is cofounder of Welch Innovation, LLC, an independent research and consulting firm and serves on the Scientific Advisory Board for Snapdragon Chemistry and Novilytic and on the board of directors for Pacifichem, Inc. His experience includes discovery synthesis of agrochemicals (Velsicol-Sandoz), development of reagents for improved immunodiagnostic assays (Abbott Laboratories), development and commercialization of chromatographic stationary phases, reagents and enantioselective catalysts within a small chemical business environment (Regis Technologies) invention and application of new purification, analysis and high throughput experimentation technologies for pharmaceutical process research (Merck & Co.) and Science Advisor for the US FDA. While at Merck, Dr. Welch created and administered a postdoctoral research fellows program and managed a multi-million-dollar fund and research network that identified, evaluated and acquired more than 300 new enabling technologies for pharmaceutical discovery and development. Dr. Welch has authored more than 300 scientific publications and patents. He is a Fellow of the American Chemical Society (2010) and the American Association for the Advancement of Science, AAAS (2013) and a recipient of the Chirality Medal (2015).
Disclosure information not submitted.
Monday, October 21, 2024
9:30 AM – 10:00 AM MT